Scarica l'app Stockscreener
2.24
3.70%
0.08
Dopo l'orario di chiusura:
2.10
-0.14
-6.25%
Precedente Chiudi:
$2.16
Aprire:
$2.21
Volume 24 ore:
31,173
Relative Volume:
0.38
Capitalizzazione di mercato:
$3.42M
Reddito:
-
Utile/perdita netta:
$-23.14M
Rapporto P/E:
-2.211
EPS:
-1.0131
Flusso di cassa netto:
$-29.23M
1 W Prestazione:
+19.79%
1M Prestazione:
-31.29%
6M Prestazione:
-72.58%
1 anno Prestazione:
-84.06%
Intervallo 1D:
$2.1001
$2.24
Intervallo di 1 settimana:
$1.87
$2.28
Portata 52W:
$1.5004
$22.06
BiomX Inc Stock (PHGE) Company Profile
Nome
BiomX Inc
Settore
Industria
Telefono
972 7 23942377
Indirizzo
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Confronta PHGE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
2.24 | 3.30M | 0 | -23.14M | -29.23M | -1.0131 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-04-15 | Iniziato | Ladenburg Thalmann | Buy |
BiomX Inc Borsa (PHGE) Ultime notizie
How interest rate cuts could boost BiomX Inc. stockWeekly Trading Summary & Community Consensus Trade Alerts - ulpravda.ru
Is BiomX Inc. stock oversold or undervaluedCPI Data & Technical Entry and Exit Alerts - ulpravda.ru
Is BiomX Inc. stock dividend yield sustainableMarket Weekly Review & High Conviction Buy Zone Alerts - ulpravda.ru
Is BiomX Inc. stock resilient to inflationNew Guidance & AI Based Buy and Sell Signals - ulpravda.ru
Is BiomX Inc. stock ready for breakoutProtective Put Strategies & Free Dynamic Profit Opportunities - ulpravda.ru
BiomX announces new preferred stock financing and warrants - MSN
Chart Watch: Will BiomX Inc stock sustain uptrend momentum2025 Key Lessons & Reliable Entry Point Trade Alerts - moha.gov.vn
Growth Report: Is BiomX Inc stock recession proofJuly 2025 EndofMonth & High Win Rate Trade Tips - moha.gov.vn
BiomX announces $3M private placement - MSN
All you need to know about BiomX (PHGE) rating upgrade to buy - MSN
BiomX Announces $3.0 Million Private Placement - The Globe and Mail
BiomX Announces New Preferred Stock Financing and Warrants - TipRanks
BiomX Signs Multiple Material Agreements - TradingView — Track All Markets
All You Need to Know About BiomX (PHGE) Rating Upgrade to Buy - Yahoo Finance
BiomX (PHGE) Secures $3M Through Private Investment Initiative - GuruFocus
RSI Suggests Rebound May Be Near in Shree Cement LimitedCash Flow Trends & Free Dynamic Profit Opportunities - earlytimes.in
Is BiomX Inc. stock a buy before product launchesJobs Report & Target Return Focused Stock Picks - DonanımHaber
Is BiomX Inc. stock recession proofEarnings Growth Report & Consistent Growth Stock Picks - DonanımHaber
Will BiomX Inc. stock outperform foreign stocksJuly 2025 Reactions & High Win Rate Trade Alerts - DonanımHaber
BiomX (NYSEAMERICAN:PHGE) Shares Up 9.9% – Still a Buy? - Defense World
What risks investors should watch in BiomX Inc. stockPortfolio Risk Report & AI Enhanced Trading Alerts - DonanımHaber
Market Rankings: Can BiomX Inc. stock reach $100 price targetJuly 2025 EndofMonth & Safe Entry Zone Tips - Улправда
BiomX collapses into court proceedings after clinical trial fails - CTech
BIOMX INCDECISION FOLLOWS SAFETY REVIEW BY INDEPENDENT DMC - 富途牛牛
BiomX Discontinues Study and Files for Insolvency - TipRanks
BiomX Inc. Discontinues Phase 2b Study and Initiates Insolvency Proceedings - TradingView — Track All Markets
BiomX (NYSE: PHGE) subsidiary seeks insolvency as Phase 2b study ends, BX011 program retained - Stock Titan
BiomX Discontinues Phase 2b Trial for BX004 - The Globe and Mail
Earnings Beat: Is BiomX Inc stock oversold or undervaluedJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - moha.gov.vn
Healthy Upside Potential: BiomX Inc (PHGE) - setenews.com
BiomX Halts Phase 2b Trial Of BX004 In Cystic Fibrosis On High Rates Of Adverse Events - Nasdaq
Stocks Tumble As Bad News Hits Biotech And Energy Sectors - Finimize
BiomX Discontinues Phase 2b Clinical Trial for BX004 - TradingView — Track All Markets
BiomX (PHGE) Halts Phase 2b Trial and Implements Cost-Saving Str - GuruFocus
BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review - The Manila Times
BiomX announces discontinuation of phase 2b Bx004 trial following internal review - marketscreener.com
US Stocks Mixed; Dow Falls Over 100 PointsCemtrex (NASDAQ:CETX), Confluent (NASDAQ:CFLT) - Benzinga
BiomX (PHGE) Price Target Increased by 964.52% to 168.30 - Nasdaq
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
BiomX (PHGE) Stock Analysis Report | Financials & Insights - Benzinga
Why BiomX Inc. stock could be top winner2025 Volatility Report & Precise Swing Trade Entry Alerts - Newser
How BiomX Inc. stock performs in high volatility marketsJuly 2025 Update & Daily Price Action Insights - Newser
BiomX Is Targeting the Infection Threat Returning to Modern WarAnd the Military Is Paying Attention (NYSE: PHGE) - markets.businessinsider.com
How BiomX Inc. stock reacts to Fed tighteningJuly 2025 Update & AI Forecasted Entry/Exit Points - Newser
How BiomX Inc. stock compares with tech leadersJuly 2025 Review & Technical Pattern Alert System - Newser
How forex fluctuations impact BiomX Inc. stockWeekly Stock Recap & High Yield Equity Trading Tips - Newser
Is BiomX Inc. stock ideal for retirement investorsMarket Growth Report & Comprehensive Market Scan Reports - Newser
How BiomX Inc. stock behaves in tightening cyclesAnalyst Downgrade & Safe Entry Trade Signal Reports - Newser
BiomX provides update on BX004 Phase 2b trial in Cystic Fibrosis - MSN
BiomX Inc Azioni (PHGE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):